Industries > Pharma > Vaccine Contract Manufacturing Market Forecast 2020-2030

Vaccine Contract Manufacturing Market Forecast 2020-2030

Prospects for Attenuated Vaccine, Inactivated Vaccine, Fluoroquinolones, Subunit Vaccines, Toxoid Vaccines PLUS analysis in leading companies within Vaccine Contract Manufacturing

PUBLISHED: 08 April 2020
PAGES: 290
PRODUCT CODE: PHA0735

Clear
WOOCS 2.2.1

The global vaccine contract manufacturing market was worth $2,241.6m in 2019 and is expected to grow at a CAGR of 9.3% from 2020-2025.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 290-page report you will receive 89 tables and 105 figures– all unavailable elsewhere.

The 290-page report provides clear detailed insight into the global vaccine contract manufacturing market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand new report today you stay better informed and ready to act.

Report Scope

• Revenue and growth forecasts from 2020 to 2030 for the global vaccine market

• Revenue and growth forecasts from 2020 to 2030 for the global vaccine contract manufacturing market

• Revenue and growth forecasts from 2020 to 2030 for the global vaccine contract manufacturing market by type:
• Attenuated Vaccines
• Inactivated Vaccines
• Fluoroquinolones
• Subunit Vaccines
• Toxoid Vaccines

Vaccine Contract Manufacturing Market Forecast 2020-2030

• Revenue and growth forecasts from 2020 to 2030 for the global vaccine contract manufacturing market by workflow:
• Downstream Processing: the revenues are further broken down into Fill & Finish Operations, Analytical & QC Studies, Packaging
• Upstream Processing: the revenues are further broken down into Mammalian Expression Systems, Bacterial Expression Systems, Yeast Expression Systems, Baculovirus/Insect Expression Systems, Other Upstream Processing

• Revenue and growth forecasts from 2020 to 2030 for the leading regional and national markets:
• North America: the revenues are further broken down into the US and Canada
• Europe: the revenues are further broken down into the UK, Germany, France, Italy and Spain
• Asia-Pacific: the revenues are further broken down into China, Japan, India and Rest of Asia-Pacific
• Latin America: the revenues are further broken down into Brazil, Mexico, and Rest of Latin America
• Middle East & Africa: the revenues are further broken into Saudi Arabia, South Africa and Rest of Middle East & Africa

The regional markets are further broken down by type and workflow.

• Discussion and profiles of the leading players in the vaccine contract manufacturing market:
• AbbVie
• Baxter BioPharma Solutions
• Boehringer Ingelheim
• Catalent
• Charles River Laboratories
• IDT Biologika
• Lonza
• Meridan Lifescience
• Pfizer
• And many more

• A SWOT analysis discussing the industry trends, strengths, weaknesses, opportunities and threats.

• Discussion on vaccine manufacturing technologies covering new substrates for vaccine production, next-generation expression systems and vectors, equipment trends, pre-filled syringes and vaccines, lyophilization and vaccine manufacturing, cell-based techniques.

• Key Questions Answered by this Report:
• How is the vaccine contract manufacturing market evolving?
• What is driving and restraining the vaccine contract manufacturing market?
• What are the market shares of the leading segments of the vaccine contract manufacturing market in 2019?
• What is the value of the leading sectors in important regions of the world?
• What will be the main driver of the overall market from 2020 to 2030?
• How will political and regulatory factors influence the regional markets and submarkets?
• Will leading national vaccine contract manufacturing markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
• How will the market shares of the leading national markets change by 2030 and which country will lead the market in 2030?
• How will the industry evolve during the period between 2020 and 2030?

Visiongain’s study is intended for anyone requiring commercial analyses for the global vaccine contract manufacturing market. You find data, trends and predictions.

Buy our report today Vaccine Contract Manufacturing Market Research: Prospects for Attenuated Vaccine, Inactivated Vaccine, Fluoroquinolones, Subunit Vaccines, Toxoid Vaccines. Avoid missing out by staying informed – order our report now.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Do you have any custom requirements we can help you with? Any need for specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com

Download sample pages

Complete the form below to download your free sample pages for Vaccine Contract Manufacturing Market Forecast 2020-2030


Download sample pages

Complete the form below to download your free sample pages for Vaccine Contract Manufacturing Market Forecast 2020-2030


Latest Pharma news

Visiongain Publishes Rare Diseases Market Report 2021-2031

As lockdowns were imposed in all the countries, diagnosis rates went down in majority of countries during the year hitting the drug sales for some period. Although lockdown measures have been eased up in most countries by mid-year 2020, this trend is expected to continue beyond 2020, stock up of medicines by patients is likely to propel the drug sales in majority of the developed economies, which account for majority of rare diseases.

02 March 2021

READ

Visiongain Publishes Respiratory Inhalers Market Report 2021-2031

Product approval is a major milestone facing all key competitors in the respiratory inhalers market. Several strategies were implemented by key market players between 2015 and Jan 2021.

26 February 2021

READ

Visiongain Publishes Bile Duct Cancer Drugs Market Report to 2031

The global bile duct cancer drug market has been growing considerably owing to the rising incidence and prevalence rate of bile duct cancer patients worldwide, technological advancement in drug development, and healthcare spending.

22 February 2021

READ

Visiongain Publishes Big Data Analytics in Healthcare Market Report to 2031

The global Big Data Analytics in Healthcare market has been growing considerably owing to the rising technological advancement, growing investment, and cohesive government policies.

22 February 2021

READ

Categories